ProSciento, mySugr Work to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions

mHealthWatchAugust 08, 2016 — By Michael Essany

Recently, ProSciento Inc., a science-driven clinical research organization (CRO), and mySugr, a diabetes mobile app developer, announced a partnership to “design and conduct a clinical research and development program for mySugr’s portfolio of diabetes mobile health applications.”

Read the full article at mHealthWatch »

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?